Cancelled Tenderocds-b5fd17-60d28e2c-9fb0-43f1-a6c6-8e1edb52c1a7

NHS England - Market Engagement - Pre Exposure Prophylaxis (PrEP) for prevention of HIV - The PrEP Impact Clinical Trial

Arden & GEM CSU on behalf of the NHS England - Specialised Commissioning would like to notify all potential bidders about a 'Market Engagement Event' which has been planned to take place on Monday 24th April 2017. This event has been arranged to provide information and seek feedback about the upcoming procurement of licensed tenofovir disoproxil/emtricitabine combined tablet formulations to meet the aims and objectives of the PrEP Impact Clinical trial. To attend this event please email your organisation's and atte...

Buyer

NHS ARDEN AND GREATER EAST MIDLANDS COMMISSIONING SUPPORT UNIT

Value

Not provided

Published

8 Jan 2018

Closes

8 Jan 2018

Procurement details

Source

Contracts Finder

Region

United Kingdom

Procurement method

Not provided

Category

Goods

Contract starts

Not provided

Contract ends

Not provided

CPV classifications

33651400

Antivirals for systemic use

Lots

Lot default NHS England - Market Engagement - Pre Exposure Prophylaxis (PrEP) for prevention of HIV - The PrEP Impact Clinical Trial

Value not provided

Arden & GEM CSU on behalf of the NHS England - Specialised Commissioning would like to notify all potential bidders about a 'Market Engagement Event' which has been planned to take place on Monday 24th April 2017. This event has been arranged to provide information and seek feedback about the upcoming procurement of licensed tenofovir disoproxil/emtricitabin...

Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom

Early engagement notice on Contracts Finder

5 Apr 2017

Early engagement notice on Contracts Finder

Market engagement notice · Web page

Early engagement notice on Contracts Finder

8 Jan 2018

Early engagement notice on Contracts Finder

Market engagement notice · Web page

Contains public sector information licensed under the Open Government Licence v3.0.